Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;35(5):716-722.
doi: 10.1007/s11596-015-1496-0. Epub 2015 Oct 22.

Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats

Jing Shi  1 , Feng Zhou  1 , Li-Kun Wang  2 , Guo-Feng Wu  3
Affiliations

Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats

Jing Shi et al. J Huazhong Univ Sci Technolog Med Sci. 2015 Oct.

Abstract

Synaptic vesicle protein 2A (SV2A) involvement has been reported in the animal models of epilepsy and in human intractable epilepsy. The difference between pharmacosensitive epilepsy and pharmacoresistant epilepsy remains poorly understood. The present study aimed to observe the hippocampus SV2A protein expression in amygdale-kindling pharmacoresistant epileptic rats. The pharmacosensitive epileptic rats served as control. Amygdaloid-kindling model of epilepsy was established in 100 healthy adult male Sprague-Dawley rats. The kindled rat model of epilepsy was used to select pharmacoresistance by testing their seizure response to phenytoin and phenobarbital. The selected pharmacoresistant rats were assigned to a pharmacoresistant epileptic group (PRE group). Another 12 pharmacosensitive epileptic rats (PSE group) served as control. Immunohistochemistry, real-time PCR and Western blotting were used to determine SV2A expression in the hippocampus tissue samples from both the PRE and the PSE rats. Immunohistochemistry staining showed that SV2A was mainly accumulated in the cytoplasm of the neurons, as well as along their dendrites throughout all subfields of the hippocampus. Immunoreactive staining level of SV2A-positive cells was 0.483 ± 0.304 in the PRE group and 0.866 ± 0.090 in the PSE group (P < 0.05). Real-time PCR analysis demonstrated that 2(-ΔΔCt) value of SV2A mRNA was 0.30 ± 0.43 in the PRE group and 0.76 ± 0.18 in the PSE group (P < 0.05). Western blotting analysis obtained the similar findings (0.27 ± 0.21 versus 1.12 ± 0.21, P < 0.05). PRE rats displayed a significant decrease of SV2A in the brain. SV2A may be associated with the pathogenesis of intractable epilepsy of the amygdaloid-kindling rats.

Keywords: amygdaloid-kindling epileptic rats; intractable epilepsy; synaptic vesicle protein 2A.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurophysiol. 2011 Sep;106(3):1227-39 - PubMed
    1. Epilepsy Res. 2000 Jun;40(1):63-77 - PubMed
    1. Eur J Pharmacol. 1995 Nov 14;286(2):137-46 - PubMed
    1. Neuroscience. 1999;94(4):1279-90 - PubMed
    1. Epilepsia. 2009 Mar;50(3):422-33 - PubMed

Publication types

MeSH terms